olivLaw · US equity research
AMRZ AMRZ
Cement, Hydraulic · SIC 3241 · Vertical: Cement, Hydraulic (SIC 3241)
Amrize Ltd (AMRZ) is a North American building solutions company spun off from Holcim in June 2025. For fiscal 2025 it reported revenues of 11815 mn USD and adjusted EBITDA of 3007 mn USD. In the second quarter of 2026 revenues rose 8.6%, and the company raised its revenue guidance but lowered adjusted EBITDA guidance because of oil-driven cost inflation.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, AMRZ (AMRZ) stock was 44.15 USD (+5.19% on the day), with market capitalisation 23.5 bn USD, P/E 19.5 on diluted EPS of 2.27 USD over the last 12 months, beta 1.24, 52-week range 36.09–65.86 USD. Latest reported quarter (Q3 2026): revenue of 3.8 bn USD (+2.2% YoY), net income of 559.0 m USD (+3.1% YoY), diluted EPS 1.02 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 71.0
- overbought (≥ 70)
- Bollinger (20, 2)
- 34.45 – 43.86
- above the upper band · %B 1.03 · band width 24.0%
- SMA 50 / 200
- 39.61 / 50.39
- mixed trend
- MACD (12, 26, 9)
- 1.03 / 0.33
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +18.7% | −1.1% | +19.8 pp | — |
| 3 months | −16.5% | −0.5% | −16.1 pp | — |
| 6 months | −19.7% | +4.4% | −24.0 pp | — |
| Year to date | −18.4% | +12.3% | −30.7 pp | — |
| 1 year | −13.4% | +13.5% | −26.9 pp | −15.4% |
| 3 years | unavailable | +76.4% | unavailable | +55.0% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.8 bn | 2.1 bn | 3.2 bn | 3.7 bn | 2.8 bn | 2.2 bn | 3.5 bn | 3.8 bn |
| Cost of revenue | 2.1 bn | 1.9 bn | 2.3 bn | 2.6 bn | 2.1 bn | 2.0 bn | 2.5 bn | 2.7 bn |
| Gross profit | 777.0 m | 237.0 m | 941.0 m | 1.1 bn | 764.0 m | 208.0 m | 993.0 m | 1.1 bn |
| SG&A | 262.0 m | 243.0 m | 286.0 m | 313.0 m | 286.0 m | 285.0 m | 283.0 m | 291.0 m |
| Operating income | 537.0 m | -5.0 m | 657.0 m | 783.0 m | 471.0 m | -72.0 m | 711.0 m | 793.0 m |
| Depreciation & amortisation | 194.0 m | 181.0 m | 187.0 m | 200.0 m | 190.0 m | 198.0 m | 217.0 m | 223.0 m |
| Interest expense | 141.0 m | 132.0 m | 143.0 m | 94.0 m | 92.0 m | 78.0 m | 94.0 m | 93.0 m |
| Pre-tax income | 361.0 m | -133.0 m | 537.0 m | 694.0 m | 388.0 m | -145.0 m | 621.0 m | 706.0 m |
| Income tax | 75.0 m | -28.0 m | 122.0 m | 158.0 m | 74.0 m | -41.0 m | 146.0 m | 153.0 m |
| Net income | 291.0 m | -94.0 m | 417.0 m | 542.0 m | 320.0 m | -105.0 m | 478.0 m | 559.0 m |
| Diluted EPS | 0.53 ≈ | -0.17 | 0.75 | 0.98 | 0.58 ≈ | -0.19 | 0.86 | 1.02 |
| Operating cash flow | 1.7 bn | -847.0 m | 406.0 m ≈ | 858.0 m ≈ | 1.8 bn | -893.0 m | 418.0 m ≈ | 697.0 m ≈ |
| Capex | 84.0 m | 213.0 m | 235.0 m ≈ | 189.0 m ≈ | 151.0 m | 275.0 m | 245.0 m ≈ | 266.0 m ≈ |
| Dividends paid | — | — | — | 0 ≈ | — | — | — | 60.0 m ≈ |
| Share repurchases | — | — | — | 0 ≈ | — | — | — | 572.0 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 17 percentile of its own 6-quarter history (min 16.5, median 23.7, max 26.5; quarters with earnings only).
Fiscal years
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 11.7 bn | 11.7 bn | 11.8 bn |
| Revenue YoY | unavailable | +0.2% | +0.9% |
| Net income | 956.0 m | 1.3 bn | 1.2 bn |
| Net income YoY | unavailable | +33.3% | −7.0% |
| Diluted EPS | 1.73 | 2.30 | 2.14 |
| Diluted EPS YoY | unavailable | +32.9% | −7.0% |
| net % | 8.2% | 10.9% | 10.0% |
| Free cash flow | 1.4 bn | 1.6 bn | 1.4 bn |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 1.9 bn USD
- Financial debt
- 4.9 bn USD
- Net debt
- 3.0 bn USD
- Equity
- 13.1 bn USD
- Total assets
- 24.2 bn USD
- Debt / equity
- 0.38x
- Current ratio
- 1.60x
- ROE
- 10.3%
- ROA
- 4.9%
- FCF margin
- 12.0%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 11.7 bn | 11.7 bn | 11.8 bn | SEC (XBRL)· 18 Feb 2026verified |
| Cost of revenue | 8.9 bn | 8.6 bn | 8.8 bn | SEC (XBRL)· 18 Feb 2026verified |
| Gross profit | 2.8 bn | 3.1 bn | 3.0 bn | SEC (XBRL)· 18 Feb 2026verified |
| SG&A | 898.0 m | 944.0 m | 1.1 bn | SEC (XBRL)· 18 Feb 2026verified |
| Operating income | 1.9 bn | 2.2 bn | 1.9 bn | SEC (XBRL)· 18 Feb 2026verified |
| Depreciation & amortisation | 689.0 m | 736.0 m | 758.0 m | SEC (XBRL)· 18 Feb 2026verified |
| EBITDA | 2.6 bn ≈ | 2.9 bn ≈ | 2.7 bn ≈ | SEC (XBRL)· 18 Feb 2026derived |
| Interest expense | 564.0 m | 547.0 m | 461.0 m | SEC (XBRL)· 18 Feb 2026verified |
| Pre-tax income | 1.3 bn | 1.6 bn | 1.5 bn | SEC (XBRL)· 18 Feb 2026verified |
| Income tax | 361.0 m | 368.0 m | 326.0 m | SEC (XBRL)· 18 Feb 2026verified |
| Net income | 956.0 m | 1.3 bn | 1.2 bn | SEC (XBRL)· 18 Feb 2026verified |
| Diluted EPS | 1.73 | 2.30 | 2.14 | SEC (XBRL)· 18 Feb 2026verified |
| Weighted average diluted shares | 553.1 m | 553.1 m | 553.6 m | SEC (XBRL)· 18 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Cash | 1.1 bn | 1.6 bn | 1.9 bn | SEC (XBRL)· 18 Feb 2026verified |
| Inventories | — | 1.5 bn | 1.5 bn | SEC (XBRL)· 10 Aug 2026verified |
| Current assets | — | 4.8 bn | 4.6 bn | SEC (XBRL)· 10 Aug 2026verified |
| Goodwill | 9.0 bn | 8.9 bn | 9.0 bn | SEC (XBRL)· 10 Aug 2026verified |
| Intangibles (excl. goodwill) | — | 1.8 bn | 1.7 bn | SEC (XBRL)· 18 Feb 2026verified |
| Total assets | — | 23.8 bn | 24.2 bn | SEC (XBRL)· 10 Aug 2026verified |
| Accounts payable | — | — | 1.5 bn | SEC (XBRL)· 10 Aug 2026verified |
| Short-term debt | — | 0 | 0 | SEC (XBRL)· 07 May 2026verified |
| Long-term debt | — | — | 4.9 bn | SEC (XBRL)· 07 May 2026verified |
| Current liabilities | — | 2.6 bn | 2.9 bn | SEC (XBRL)· 10 Aug 2026verified |
| Total liabilities | — | 13.9 bn | 11.1 bn | SEC (XBRL)· 10 Aug 2026verified |
| Equity | 9.2 bn | 9.8 bn | 13.1 bn | SEC (XBRL)· 10 Aug 2026verified |
| Shares outstanding at year end | — | — | 553.1 m | SEC (XBRL)· 18 Feb 2026verified |
Cash flow · USD
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 2.0 bn | 2.3 bn | 2.2 bn | SEC (XBRL)· 18 Feb 2026verified |
| Capex | 630.0 m | 642.0 m | 788.0 m | SEC (XBRL)· 18 Feb 2026verified |
| Free cash flow | 1.4 bn ≈ | 1.6 bn ≈ | 1.4 bn ≈ | SEC (XBRL)· 18 Feb 2026derived |
| Investing cash flow | -2.0 bn | -1.2 bn | -361.0 m | SEC (XBRL)· 18 Feb 2026verified |
| Financing cash flow | 734.0 m | -537.0 m | -1.6 bn | SEC (XBRL)· 18 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 56 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 23.5 bn USD
Key indicators
Coverage and freshness
Score by group
- Quality66
- Valuation48
- Balance sheet54
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 25.19 – 46.18 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)25.19 – 46.18 (Mid 33.07)WACC 8.5% · starting FCFF 1.4 bn USD · terminal value share of EV 75%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 11.3%
- Peers: EV/EBITDAunavailable · not enough peers
- Peers: P/Eunavailable · not enough peers
- Dividend discount (DDM)unavailable · input data missing
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 56/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 10.0% | 61 (on a fixed band) | 14% |
| Net margin · Quality | 10.2% | 60 (vs peers) | 9% |
| FCF conversion · Quality | 85.9% | 80 (on a fixed band) | 9% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | 1.8x | 64 (on a fixed band) | 14% |
| Interest coverage · Balance sheet | 5.3x | 59 (on a fixed band) | 9% |
| Current ratio · Balance sheet | 1.1x | 22 (on a fixed band) | 6% |
| P/E (TTM) · Valuation | 19.5x | 48 (on a fixed band) | 14% |
| EV/EBITDA · Valuation | 10.4x | 42 (on a fixed band) | 14% |
| FCF yield · Valuation | 4.6% | 57 (on a fixed band) | 11% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet54/100 · 3/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality66/100 · 3/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation48/100 · 3/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Amrize Ltd (AMRZ). Latest full fiscal year: 2025; data up to 2026-09-30.
Figures computed from the financial statements: revenue 11.8 bn USD in 2025; YoY growth 0.9%; net margin 10.2%; ROE 9.8%; net debt/EBITDA 1.8x.
The estimated value range is 25.19–46.18 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 33.07 USD, the price of 44.15 USD leaves a potential of -25.1% (value / price − 1) and a margin of safety of -33.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 56/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth, returns. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- FCF conversion: 85.9%
What contradicts it
- Current ratio: 1.1x
Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Cement, Hydraulic (SIC 3241) · same industry (4-digit SIC) · compared with 5 companies
The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| CXCemex Sab De Cv | 155.4 bn | 502.8 | 7.8% | 5.8% | −2.1% | −1% / +55% |
| CRHCRH public limited company | 65.7 bn | 18.6 | 14.8% | 9.2% | +5.3% | −18% / +57% |
| AMRZAmrize Ltd | 23.5 bn | 19.5 | 9.8% | 10.2% | +0.9% | −13% / unavailable |
| EXPEagle Materials Inc. | 5.8 bn | 15.7 | 24.5% | 16.1% | +2.1% | −15% / +5% |
| LOMALoma Negra Compania Industrialargentina Sociedad Anonima | — | — | 21.5% | 22.0% | −23.9% | −29% / +35% |
| CPACHolcim Ltd | — | — | 16.6% | 10.1% | +1.4% | +90% / +170% |
1- and 3-year price returns: for AMRZ from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 26.10 Total return -41% · Per year -41% | 46.22 Total return 5% · Per year 5% | 69.74 Total return 58% · Per year 58% |
| 3 years | 23.55 Total return -47% · Per year -19% | 47.11 Total return 7% · Per year 2% | 78.28 Total return 77% · Per year 21% |
| 5 years | 21.26 Total return -52% · Per year -14% | 48.00 Total return 9% · Per year 2% | 87.87 Total return 99% · Per year 15% |
- Exit P/E± 11.78
- Net margin± 8.24
- Annual revenue growth± 7.01
- Annual dilution± 0.69
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 10 Aug 2026; since then the company filed 10-Q (29 Oct 2026), 8-K (28 Oct 2026 · results).
In brief
Amrize Ltd (AMRZ) is a North American building solutions company spun off from Holcim in June 2025. For fiscal 2025 it reported revenues of 11815 mn USD 1 and adjusted EBITDA of 3007 mn USD 1. In the second quarter of 2026 revenues rose 8.6% 3, and the company raised its revenue guidance but lowered adjusted EBITDA guidance because of oil-driven cost inflation 3.
SWOT
Strengths
Weaknesses
- Energy and fuel costs have a significant effect on results, and the company has already lowered EBITDA guidance because of them 13.
- The cost base includes large fixed and semi-fixed costs, so earnings are sensitive to volume changes 1.
- The company has a short history as an independent listed entity, which limits comparison with earlier results 1.
Opportunities
- Bolt-on acquisitions in fragmented aggregates and concrete markets could extend the business, in line with the stated strategy 12.
- If large data centre and energy projects continue, demand for cement and building solutions could stay elevated 3.
- The ASPIRE cost programme could ease operating cost pressure in the second half of the year 3.
Threats
Risks
- Energy and fuel costshigh
Higher energy and fuel prices can compress margins, and the company has already adjusted guidance for this factor 13.
- Dependence on construction activityhigh
Demand depends on construction activity and public funding, and a downturn could affect results 1.
- Environmental regulationmedium
Operations are subject to environmental laws and permits, and regulatory changes could raise costs or delay projects 1.
- Acquisition integrationmedium
The company may struggle to integrate acquisitions and capture the expected benefits, especially in aggregates and roofing 1.
- Holcim separation costslow
Non-recurring separation costs could exceed expectations, and the short history as an independent company limits comparability 1.
Investment thesis
What would need to be true (bull case)
- If demand from large projects and aggregates pricing hold, revenue growth could continue through the second half of the year 3.
- Strong positions in aggregates and roofing, together with the ASPIRE programme, could support margins over the longer term 13.
- If the share repurchase programme and dividends continue, the company could keep returning capital to shareholders 3.
What would break the thesis
- If oil prices stay high, freight and raw material costs could reduce EBITDA by more than currently expected 3.
- Residential demand and public infrastructure are sensitive to economic cycles and government decisions, which could slow growth 1.
- If separation and integration costs extend, profitability could remain below expectations in the period ahead 1.
What to watch
- Delivery against 2026 revenue and adjusted EBITDA guidancenext 10-K
- Trend in energy and diesel costs in the second half of the yearQ3 2026
- Progress and savings from the ASPIRE programme2026
- Holcim separation and rebranding costs2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 10 Aug 2026; since then the company filed 10-Q (29 Oct 2026), 8-K (28 Oct 2026 · results).
The business
Amrize earns revenue from cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building solutions, serving infrastructure, commercial and residential construction customers in the United States and Canada 1. It has more than 19000 employees and more than 1000 sites 1. Its shares are listed on the New York Stock Exchange and the SIX Swiss Exchange under the symbol AMRZ 1.
The strategy centres on profitable growth through disciplined acquisitions, especially in aggregates and in the Building Envelope segment, while keeping an investment grade credit rating 1. In 2025 the company reduced external borrowings and streamlined its corporate cost structure after the separation from Holcim 1.
Repair and refurbishment (R&R) work accounted for 43% of overall revenues in 2025 1, so demand depends not only on new construction but also on maintaining existing buildings.
Segments
Building Materials
The Building Materials segment includes cement, aggregates, ready-mix concrete and asphalt 1. Beyond cement and aggregates sales, the segment benefits from higher aggregates prices, according to the August 2026 release 3.
Market context
Trends
- Demand from large projectstailwind
Demand from large projects, including data centres, energy and advanced manufacturing, supported revenue growth in the second quarter of 2026 3. If this project pipeline slows, growth could weaken.
- Oil priceheadwind
Higher oil prices raised freight, diesel and raw material costs, and the company lowered its EBITDA guidance as a result 3. If this pressure persists, margins could stay under strain.
- Cement and aggregates pricingtailwind
The company expects continued strong pricing for cement and aggregates in the second half of 2026 3. This could partly offset higher costs, though the effect depends on how well prices are realised.
- Separation costsmixed
Spin-off and separation costs, including rebranding, are expected to continue through fiscal 2027 12. They weigh on reported results for now, although they are largely non-recurring.
Competitive position
In the United States, the principal competitors in cement and aggregates are Cemex, Buzzi-Unicem, Heidelberg Materials and CRH, alongside many local and regional players 1. Ready-mix concrete is highly fragmented and competitive 1.
In Building Envelope, competitors include Carlisle, CertainTeed, GAF, Johns Manville, Owens Corning and RPM 1. Competition turns on scale, innovation, distribution and customer service 1.
- Cemex
Principal competitor in cement and aggregates in the United States, named in the annual report 1.
- Heidelberg Materials
Cement and aggregates producer named as a principal competitor in the United States 1.
- CRH
Construction materials company named as a principal competitor in cement and aggregates 1.
- Owens Corning
Competitor in insulation and roofing systems within the Building Envelope segment 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Quarterly report29 Oct 2026
- Current report28 Oct 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Current report11 Sept 2026Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Current report01 Sept 2026Departure or appointment of officers
- Current report24 Aug 2026Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report10 Aug 2026
- Current report06 Aug 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report07 May 2026
- Current report29 Apr 2026Results of operations · Regulation FD disclosure
- Current report21 Apr 2026Shareholder vote · Other events · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / AMRZ · 18 Feb 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / AMRZ · 10 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / AMRZ · 06 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.